← Back to Search

'LIFEView' for Disease

N/A
Waitlist Available
Led By Rebekah Hackbusch
Research Sponsored by Bruyere Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
• Any patients who are able to complete the outcome measures (Section 5.0 Outcomes) and capable of consenting to participating in the research study will be included.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at least 24 hours before using 'lifeview', and directly after using 'lifeview' (pre- and post-'lifeview')
Awards & highlights

Study Summary

This trial is looking at whether the audio-video technology 'LIFEView' can help improve wellbeing for people receiving palliative care. The software is loaded onto a laptop and connected to a TV, so it can be used by people who may be disoriented or have reduced physical mobility.

Eligible Conditions
  • End-Stage Disease
  • Quality of Life
  • Psychological Distress
  • Palliative Care

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at least 24 hours before using 'lifeview', and directly after and 48 hours after using 'lifeview' (pre- and post-'lifeview')
This trial's timeline: 3 weeks for screening, Varies for treatment, and at least 24 hours before using 'lifeview', and directly after and 48 hours after using 'lifeview' (pre- and post-'lifeview') for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in psychological and physical symptoms measured by the Edmonton Symptom Assessment System-revised (ESAS-r) (Bruera et al., 1991; Watanabe et al., 2011)
Secondary outcome measures
Change in blood pressure
Change in heart rate
Change in quality of life measured by the McGill Quality of Life-Revised questionnaire (Cohen et al., 2017)
+1 more
Other outcome measures
Aspects of participant's level of general well-being as per the Greater Cincinnati Chapter Well-Being Observation tool (Rentz, 2002; Kinney & Rentz, 2005) during the 'LIFEView' session, and other observable phenomena

Trial Design

1Treatment groups
Experimental Treatment
Group I: 'LIFEView' interventionExperimental Treatment1 Intervention
The 'LIFEView' session(s) involves the use of audiovisual software by Motitech AS (technology provided by and used with permission from Motitech AS). For its primary uses as Motiview, the audiovisual software was coupled to a mobile user-adapted cycle-trainer. Since a secondary benefit of the virtual cycle trip may include reminiscence which may in-turn facilitate conversation of past experiences, the audiovisual software is being adapted for use in reminiscence therapy for a palliative care population. As there is an extensive library available to participants and 'LIFEView' sessions could potentially be longer than feasible for research personnel to conduct, each 'LIFEView' session will be limited to up to 3 videos per session or up to 1 hour of videos per session, whichever is a shorter duration. Additional post-study 'LIFEView' sessions can be provided upon request from participants.

Find a Location

Who is running the clinical trial?

Bruyere Research InstituteLead Sponsor
34 Previous Clinical Trials
2,024,181 Total Patients Enrolled
Bruyere Continuing CareUNKNOWN
Rebekah HackbuschPrincipal InvestigatorBruyère Continuing Care

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are the researchers behind this trial looking for additional participants?

"That is correct. Per the clinicaltrials.gov website, this trial posted on October 16th 2019 and was recently updated on July 22nd 2021 is actively searching for 92 participants at a single medical centre."

Answered by AI

What is the projected participant count for this research project?

"Affirmative. The clinical trial's profile on clinicaltrials.gov reveals that it is presently enrolling patients, having been initially posted on October 16th 2019 and recently updated on July 22nd 2021. A total of 92 individuals need to be recruited at a single medical site."

Answered by AI
Recent research and studies
~7 spots leftby Apr 2025